BCL2 interacting protein 3 pseudogene 10 (BNIP3P10)

BCL2 interacting protein 3 pseudogene 10 (BNIP3P10) is classified as a **pseudogene**, meaning it is a segment of DNA that is similar to a known gene (in this case, *BNIP3*), but it is not transcribed into a functional protein[2]. Pseudogenes generally lack biological function and are not considered therapeutic targets, receptors, or enzymes. BNIP3P10 is related by sequence to the functional *BNIP3* gene, which is a pro-apoptotic member of the BCL2 family and involved in cell death and autophagy, but BNIP3P10 itself does not have protein-coding capability and is not known to have a direct biological or disease role[2]. **Key Clarifications:** - BNIP3P10 is not a receptor, enzyme, transporter, or any druggable target. - There is nothing therapeutically actionable or functionally relevant known about BNIP3P10 as per major gene and protein databases—it is simply classified as a pseudogene[2]. - Functional or disease roles, interacting drugs, or biomarkers are reported only for the protein-coding family members (such as BNIP3 and BNIP3L), not for BNIP3P10[3][7]. - If the intent of the query was *BNIP3* or *BNIP3-like (BNIP3L)*, those are protein-coding genes with significant apoptotic and autophagic roles[3][5][7]. **Summary:** **BNIP3P10** is a pseudogene, does not encode a functional protein, and is not considered a therapeutic target. There is no evidence of biological function, drug interaction, or disease relevance for this sequence, and its mention as a target appears to be an error[2]. If information on BNIP3 (the functional apoptosis regulator) is needed, clarification is recommended.

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 10BNIP3P10[2]